摘要 |
Novel indole derivatives of formula (I) or a pharmaceutically acceptable salt thereof: wherein R<SUP>1 </SUP>is fluorine, or chlorine, and R<SUP>2 </SUP>is hydrogen, or fluorine, which are SGLT inhibitors and are useful for treatment or prevention of diabetes and related conditions.
|